Login

Balance Sheets

In millions of USD, except per-share amounts
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q3 FY2021
As of Sep 30, 2021
Q2 FY2021
As of Jun 30, 2021
Q1 FY2021
As of Mar 31, 2021
Q4 FY2020
As of Dec 31, 2020
Assets
Cash
Deferred offering costs
Prepaid Expenses
Total Current Assets
Cash in Trust Account
Marketable securities held in Trust Account
Total Assets
Accrued expenses
Accrued offering costs
Current Liabilities
Accounts payable and accrued expenses
Income taxes payable
Promissory note - related party
Promissory note – related party
Total Current Liabilities
Private Placement Warrants derivative liability
Deferred underwriting fee
Public Warrants derivative liability
Deferred underwriting fee
Public Warrants derivative liability
Private Placement Warrants deriviative liability
Total Liabilities
Class A common stock subject to possible redemption, 962,093 shares at redemption value at December 31, 2022 and 12,500,500 shares at December 31, 2021
Stockholders’ Deficit
Class A common stock, $0.0001 par value; 100,000,000 shares authorized
Class B common stock, $0.0001 par value; 10,000,000 shares authorized: 3,125,125 shares issued and outstanding at March 31, 2021 and December 31, 2020
Class B common stock, $0.0001 par value; 10,000,000 shares authorized: 3,125,125 shares issued and outstanding at December 31, 2022 and 2021
Additional paid-in capital
Accumulated deficit
Stockholders’ Deficit
Class B common stock
Total Stockholders’ Deficit
Total Liabilities and Stockholders’ Deficit

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support